Close

New Potential Safety Signal With Ocaliva Represents a New Overhang for Intercept Pharmaceuticals (ICPT) - BMO Oct 8, 2020 01:46PM
Intercept Pharmaceuticals (ICPT) PT Raised to $56 at BMO Capital, Following Earnings Aug 10, 2020 03:39PM
BMO Capital Downgrades Intercept Pharmaceuticals (ICPT) to Market Perform, After Receiveing Complete Response Letter From FDA Jun 29, 2020 01:29PM
UPDATE: BMO Capital Starts Intercept Pharmaceuticals (ICPT) at Outperform Jun 4, 2020 04:07PM
Intercept Pharmaceuticals (ICPT) PT Raised to $155 at BMO Capital Feb 15, 2018 08:16AM
View Older Stories

Dec 7, 2017 04:05PM Intercept to Present at Upcoming Conference
Sep 25, 2017 12:07PM Intercept Pharma (ICPT) Price Target $160 Maintained at BMO Capital
Sep 21, 2017 04:08PM Intercept Pharmaceuticals (ICPT) PT Lowered to $160 at BMO Capital After FDA Outlines Ocaliva SAE
Sep 19, 2017 07:36AM Intercept Pharma (ICPT): Management Meetings Soothe Investor Fears Ahead Of Catalyst - BMO
Sep 12, 2017 11:56AM Buy Weakness in Intercept Pharmaceuticals (ICPT) - BMO
Aug 1, 2017 10:21AM Intercept Pharmaceuticals (ICPT) PT Raised to $221 at BMO Capital on 2Q Report; 'Solid 2Q17 Earnings + Two Positive Phase 2 Readouts... Buy on Weakness'
Jul 31, 2017 09:32AM Pre-Open Stock Movers 07/31: (DVAX) (CHTR) (DAN) Higher; (HTZ) (CLVS) (ICPT) Lower (more...)
May 5, 2017 07:25AM Intercept Pharmaceuticals (ICPT) PT Raised to $223 at BMO Capital; 'Ocaliva Off to a Strong Start'
Feb 24, 2017 08:26AM Intercept Pharmaceuticals (ICPT) PT Raised to $221 at BMO Capital
Feb 10, 2017 11:40AM Intercept Pharmaceuticals (ICPT) NASH Trial Changes Increase Probability of Success and Timely Approval - BMO
Aug 22, 2016 09:41AM Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
Aug 4, 2016 01:55PM Intercept (ICPT) OCA Off to Gradual Start in PBC, BMO Capital Notes; PT to $218
May 31, 2016 01:54PM Intercept (ICP) OCA Approval a 'Major De-Risking Event' - BMO
May 3, 2016 12:15PM Streetinsider.com's Hot Lunchtime Reads 5/3: (AAPL) (ICPT) (VRX) (TSLA)
May 3, 2016 11:31AM Intercept Pharmaceuticals (ICPT) Settlement Removes Minor Overhang - BMO Capital
Apr 7, 2016 10:28AM Notable Analyst Rating Changes 4/7: (MTH) (GT) (CBRL) Upgraded; (VZ) (HOG) (FFIV) Downgraded
Apr 6, 2016 06:09PM After-Hours Stock Movers 04/06: (OLLI) (APOG) (VRX) Higher; (RPTP) (ALDR) (EBAY) Lower (more...)
Apr 6, 2016 04:22PM BMO Capital Starts Intercept Pharmaceuticals (ICPT) at Outperform
Apr 5, 2016 10:32AM Notable Analyst Rating Changes 4/5: (CHMT) (SXL) (ICPT) Upgraded; (LPLA) (LYB) (HRL) Downgraded
May 19, 2015 11:03AM BMO Capital Says Buy Intercept Pharmaceuticals (ICPT) on Weakness Related to Trial Design
Mar 20, 2015 10:01AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital Amid Data
Mar 5, 2015 08:27AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital as Competitor Data in PBC Support Role of OCA
Feb 10, 2015 04:05PM Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
Feb 5, 2015 06:41AM Intercept Pharma (ICPT) 1M Stock Offering Prices at $176/Share
Feb 4, 2015 07:34PM Intercept Pharmaceuticals Announces Pricing of Public Offering
Jan 21, 2015 09:40AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital amid American Journal of Pathology OCA Data
Dec 16, 2014 11:20AM Genfit Data Not Seen as Competitive Threat to Intercept Pharmaceuticals (ICPT) - BMO Capital
Dec 4, 2014 10:33AM Notable Analyst Rating Changes 12/4: (INFI) (MBLY) (CSX) Upgraded; (DISH) (RIO) (WMT) Downgraded
Nov 10, 2014 08:30AM BMO Capital Retains Bullish Stance on Intercept Pharmaceuticals (ICPT) Following Q3 Results, FLINT Data
Nov 7, 2014 06:33AM Balanced Intercept (ICPT) FLINT Review Will Leave Near-Term Debate, BMO Capital Says
Oct 8, 2014 08:52AM BMO Capital Affirms Intercept (ICPT) at 'Outperform'; FLINT Data Won't be Presented at AASLD
Aug 12, 2014 10:49AM Notable Analyst Rating Changes 08/12: (ANF) (ICUI) (DF) Upgraded; (AMCC) (WHX) (TCK) Downgraded
Aug 12, 2014 09:07AM Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital Following FLINT Data
Jul 29, 2014 03:38PM Galectin (GALT) Disappointment Positive for Intercept Pharmaceuticals (ICPT) - BMO Capital
Jun 27, 2014 09:48AM Intercept Pharma (ICPT) Higher after 2-Day Slide
May 20, 2014 10:07AM Amid E-Mails and Phone Records, BMO Capital Believes Intercept (ICPT) FLINT Trial Was Stopped Early For Efficacy
May 15, 2014 10:28AM Notable Analyst Rating Changes 05/15: (PLUG) (PTX) (TWTR) Upgraded; (BMY) (HII) (CXP) Downgraded
Apr 4, 2014 06:29AM Intercept Pharma (ICPT) Prices 1M Common Offering at $320/Share
Apr 3, 2014 08:41PM Intercept Pharmaceuticals Announces Pricing of Public Offering
Apr 1, 2014 05:38PM Intercept Pharma (ICPT) to Offer 1M Shares
Apr 1, 2014 05:36PM Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 1, 2014 12:18PM Streetinsider.com's Hot Lunchtime Reads 04/01: (ICPT) (ISRG) (MSFT) (DDD)
Apr 1, 2014 11:16AM Intercept (ICPT) Competitive Risk from Galectin (GALT) 'Deminimus' - BMO Capital
Mar 24, 2014 11:34AM Stocks Weaker, Led by High-Beta Names
Mar 17, 2014 06:23AM Intercept (ICPT) Positive POISE Trial Helps Balance FLINT CV Risk, BMO Capital Says
Jan 13, 2014 08:28AM Intercept Pharmaceuticals (ICPT) Price Target Raised to $515 at BMO
Jan 9, 2014 10:00AM Intercept Pharmaceuticals (ICPT) Target Raised to $270 at BMO Capital
Jun 19, 2013 06:30AM Intercept Pharma (ICPT) Prices 1.73M Common Offering at $33.01/Share
Nov 5, 2012 12:10PM BMO Capital Starts Intercept Pharmaceuticals (ICPT) at Outperform
Oct 11, 2012 11:39AM Intercept Pharmaceuticals (ICPT) IPO Trades 26% Higher
View Older Stories